Global Michael J. Rider - 11 Nov 2026 Form 4 Insider Report for RESMED INC (RMD)

Reporting relationship: Global General Counsel
Issuer ticker: RMD
Reported as of: 11 Nov 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 Nov 2026, 06:03:09 UTC
Prior SEC filing: 26 Oct 2026
Source filing: View source filing
Reporting owner signature: /s/ Michael J. Rider, Global General Counsel and Secretary

Filing notes and source

Key filing fact

Global Michael J. Rider filed Form 4 for RESMED INC (RMD) on 13 Nov 2026.

Key facts

This page summarizes Global Michael J. Rider's Form 4 filing for RESMED INC (RMD).
4 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 13 Nov 2026, 06:03.

Change

Previous filing in this sequence was filed on 26 Oct 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001982205 Primary reporting owner

Rider Michael J

Relationship: Global General Counsel
Address: 9001 SPECTRUM CENTER BLVD, SAN DIEGO
Signature: /s/ Michael J. Rider, Global General Counsel and Secretary
Signature date: 13 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RMD transaction

ResMed Common Stock

Tax liability

Transaction value
Shares: -547
Change %: -4.4%
Price: $234.11^*
Shares after: 11,813
Date: 11 Nov 2026
Ownership: Direct
Footnotes: F1

RMD transaction

ResMed Common Stock

Tax liability

Transaction value
Shares: -499
Change %: -4.2%
Price: $234.11^*
Shares after: 11,314
Date: 11 Nov 2026
Ownership: Direct
Footnotes: F2

RMD transaction

ResMed Common Stock

Tax liability

Transaction value
Shares: -724
Change %: -6.4%
Price: $234.11^*
Shares after: 10,590
Date: 11 Nov 2026
Ownership: Direct
Footnotes: F3

RMD transaction

ResMed Common Stock

Tax liability

Transaction value
Shares: -173
Change %: -1.6%
Price: $234.11^*
Shares after: 10,417
Date: 11 Nov 2026
Ownership: Direct
Footnotes: F4, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/20/2025.

Footnote F2

Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/20/2024.

Footnote F3

Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2023.

Footnote F4

Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2022.

Footnote F5

Includes 41.7624 shares of Resmed stock purchased on Oct 30, 2026 through the Resmed Employee Stock Purchase Plan.